94 related articles for article (PubMed ID: 23859481)
1. Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.
Fiskvik I; Aamot HV; Delabie J; Smeland EB; Stokke T; Heim S; Holte H
Eur J Haematol; 2013 Oct; 91(4):332-8. PubMed ID: 23859481
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
[TBL] [Abstract][Full Text] [Related]
4. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
[TBL] [Abstract][Full Text] [Related]
6. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.
Dicker F; Herholz H; Schnittger S; Nakao A; Patten N; Wu L; Kern W; Haferlach T; Haferlach C
Leukemia; 2009 Jan; 23(1):117-24. PubMed ID: 18843282
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
Shimono J; Miyoshi H; Kiyasu J; Kamimura T; Eto T; Miyagishima T; Nagafuji K; Seto M; Teshima T; Ohshima K
PLoS One; 2018; 13(4):e0194525. PubMed ID: 29641580
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas.
Beà S; Colomo L; López-Guillermo A; Salaverria I; Puig X; Pinyol M; Rives S; Montserrat E; Campo E
J Clin Oncol; 2004 Sep; 22(17):3498-506. PubMed ID: 15337798
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma.
Kaneko H; Shimura K; Horiike S; Kuroda J; Matsumoto Y; Yokota S; Nishida K; Ohkawara Y; Taniwaki M
Asia Pac J Clin Oncol; 2011 Dec; 7(4):346-50. PubMed ID: 22151983
[TBL] [Abstract][Full Text] [Related]
10. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
Stokke T; DeAngelis P; Smedshammer L; Galteland E; Steen HB; Smeland EB; Delabie J; Holte H
Br J Cancer; 2001 Dec; 85(12):1900-13. PubMed ID: 11747333
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
[TBL] [Abstract][Full Text] [Related]
13. The molecular cytogenetic aberration analyzed by comparative genomic hybridization and its significance in diffuse large B-cell lymphoma.
Xia HL; Chen LJ; Chen B; Jin XL; Chen SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):12-5. PubMed ID: 16456777
[TBL] [Abstract][Full Text] [Related]
14. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
[TBL] [Abstract][Full Text] [Related]
15. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.
Van Den Neste E; Robin V; Francart J; Hagemeijer A; Stul M; Vandenberghe P; Delannoy A; Sonet A; Deneys V; Costantini S; Ferrant A; Robert A; Michaux L
Leukemia; 2007 Aug; 21(8):1715-22. PubMed ID: 17541398
[TBL] [Abstract][Full Text] [Related]
17. Karyotype and prognosis in non-Hodgkin lymphoma.
Pirc-Danoewinata H; Chott A; Onderka E; Drach J; Schlögl E; Jäger U; Thalhammer F; Nowotny H; Aryee D; Steger GG
Leukemia; 1994 Nov; 8(11):1929-39. PubMed ID: 7967739
[TBL] [Abstract][Full Text] [Related]
18. The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma.
Visco C; Canal F; Parolini C; Andreoli A; Ambrosetti A; Krampera M; Lestani M; Pizzolo G; Chilosi M
Haematologica; 2006 May; 91(5):687-90. PubMed ID: 16670073
[TBL] [Abstract][Full Text] [Related]
19. Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma.
Cabanillas F; Pathak S; Trujillo J; Manning J; Katz R; McLaughlin P; Velasquez WS; Hagemeister FB; Goodacre A; Cork A
Cancer Res; 1988 Oct; 48(19):5557-64. PubMed ID: 3416308
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]